Research Fellow Dr Matthew Mold Speaks at Indian Institute of Technology, Kanpur
Dr Mold said of the meeting: “I was thrilled to receive the award and for the opportunity to present my research to like-minded academics. I am confident that newly forged collaborations between research institutions in both the UK and India will have a positive output in manipulating peptide-metal interactions to target disease”.
Dr Mold was funded by the Newton Bhabha fund to attend the 'Peptides, Proteins and Metals in Disease & Therapy' workshop at the Indian Institute of Technology, Kanpur.
Dr Matthew Mold, a Children’s Medical Safety Research Institute (CMSRI) Research Fellow working with Prof. Christopher Exley in The Birchall Centre, attended the workshop, hosted at the Indian Institute of Technology (IIT), from the 6th – 8th November in Kanpur, India. Funded jointly by the Royal Society of Chemistry (RSC) and The British Council, Dr Mold attended the meeting through a Newton Bhabha Researcher Links travel award, aimed at early career researchers. Dr Mold gave an oral presentation to academics from across the UK and India on his research using direct fluorescent labels to follow the fate of amyloid vaccines in a cellular model of Alzheimer’s disease.
The workshop, coordinated by Prof. Peter Sadler from the University of Warwick and Prof. Sandeep Verma from IIT, addressed the challenges associated with developing new therapies targeting the protein-misfolding disorders, most commonly associated with the neurodegenerative diseases. The workshop explored how such advances could be significantly enhanced by UK-India cooperation, pooling resources and expertise across interdisciplinary research themes.